It is indicated for:
It is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 12 months of age and older.
Exercise-Induced Bronchoconstriction (EIB)
It is indicated for prevention of exercise-induced bronchoconstriction (EIB) in patients 6 years of age and older.
Montelukast sodium is indicated for the relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in patients 6 months of age and older.